Have you read our July issue yet? If you are looking for a place to start, check out this #OpenAccess publication that ISCT, International Society for Cell & Gene Therapy European Committee wrote in collaboration with The EBMT. The current challenges facing the translation of cell and gene therapies in Europe are explored, with recommendations on expanding registries for real-world assessment, the role of accreditation in protecting patients, and the importance of developing the sector's workforce are highlighted, among other key issues by Fermin Sanchez-Guijo, Joaquim Vives, Annalisa Ruggeri, Christian CHABANNON, Selim Corbacioglu, Harry Dolstra, Dominique FARGE, Nico Gagelmann, Claire Horgan, Jurgen Kuball, bénédicte Neven, Tuula Rintala, Vanderson Rocha, Isabel Sanchez-Ortega, Professor JOHN SNOWDEN, Jaap Jan Zwaginga, Massimiliano Gnecchi, Anna Sureda Balari. https://lnkd.in/geRErgZZ
Cytotherapy’s Post
More Relevant Posts
-
Curious to learn how #mitochondria may be able to open the next frontiers in gene therapy? Dedy Septiadi, PhD, Gabriele Alessandro Fontana, and Martijn Brugman are presenting cellvie's latest insights at the annual meeting of the European Society of Gene and Cell Therapy. If you are attending, meet the team at today's Poster Session III, between 14:00 - 15:30; Concourse Level -1 and Mezzanine Concourse; number P0963. Or just reach out to them to arrange a meet-up. Title: Mitochondria as versatile vehicles for therapeutic gene delivery #mitochondria #genethreapy cellvie
-
-
Operationalizing #cellandgenetherapy trials is a significant and complex task that takes expert planning and implementation. Check out our webinar (https://lnkd.in/g87QdfCj) where Allucent experts Desmond Cabrera (VP, Project Management), Joyce Moore, PhD (Global Head, Patient Engagement), Francisca Samson - Graveland (Director, Data Management), and Marita Kruskopf Osterberg, PhD (Senior Manager, Study Start-Up) share insights and strategies on how to successfully conduct cell and gene therapy trials. #Allucent #BringNewTherapiesToLight #DrugDiscovery #ClinicalTrials #PatientEngagement #DrugDevelopment
-
-
𝐋𝐨𝐧𝐠, 𝐏𝐮𝐫𝐞, 𝐂𝐨𝐦𝐩𝐥𝐞𝐱, 𝐒𝐜𝐚𝐥𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐌𝐮𝐥𝐭𝐢𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐢𝐧𝐠𝐥𝐞-𝐒𝐭𝐫𝐚𝐧𝐝𝐞𝐝 𝐃𝐍𝐀 – 𝐀 𝐂𝐥𝐨𝐬𝐞-𝐮𝐩 𝐋𝐨𝐨𝐤 𝐚𝐭 𝐌𝐨𝐥𝐢𝐠𝐨 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 🔎 Moligo Technologies CEO Cosimo Ducani, Ph.D. discusses the start-up’s unique approach to developing single-stranded DNA that is long, pure, complex, scalable and multifunctional, the urgent need for non-viral cell and gene therapies, and much more in our latest interview. Read more at the link below or catch Cosimo at the European Society of Gene and Cell Therapy Congress in Rome this week. https://lnkd.in/eVn8eeym #crisprmedicinenews #crisprmedicine #crispr #geneediting #geneticmedicines #moligotechnologies #nonviraltherapies #DNAsynthesis
-
-
In my latest interview for CRISPR Medicine News, I spoke with Cosimo Ducani (CEO of Karolinska Institutet spin-out Moligo Technologies) to hear about the company's unique approach to DNA synthesis and visions for a future of non-viral genetic medicine. Check it out in the post below👇🏻 #crisprmedicinenews #crisprmedicine #crispr #geneediting #geneticmedicines #moligotechnologies #nonviraltherapies #DNAsynthesis
𝐋𝐨𝐧𝐠, 𝐏𝐮𝐫𝐞, 𝐂𝐨𝐦𝐩𝐥𝐞𝐱, 𝐒𝐜𝐚𝐥𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐌𝐮𝐥𝐭𝐢𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐢𝐧𝐠𝐥𝐞-𝐒𝐭𝐫𝐚𝐧𝐝𝐞𝐝 𝐃𝐍𝐀 – 𝐀 𝐂𝐥𝐨𝐬𝐞-𝐮𝐩 𝐋𝐨𝐨𝐤 𝐚𝐭 𝐌𝐨𝐥𝐢𝐠𝐨 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 🔎 Moligo Technologies CEO Cosimo Ducani, Ph.D. discusses the start-up’s unique approach to developing single-stranded DNA that is long, pure, complex, scalable and multifunctional, the urgent need for non-viral cell and gene therapies, and much more in our latest interview. Read more at the link below or catch Cosimo at the European Society of Gene and Cell Therapy Congress in Rome this week. https://lnkd.in/eVn8eeym #crisprmedicinenews #crisprmedicine #crispr #geneediting #geneticmedicines #moligotechnologies #nonviraltherapies #DNAsynthesis
-
-
🚀 Counting down the days to the Terrapinn #advancedtherapies Congress on 19-20 March in London! 📆 Looking forward to meeting cell and gene therapy experts! By the way - mates special rates expire on 23rd February! #cellandgenetherapy #cellandgenetherapies #futureofmedicine
-
🔍 Insights on Industrial Partnerships at Carnot Imagine : We are thrilled to share the latest communication of our partner Cellectis in Nature Communications, including results obtained in partnership with Dr Annarita Miccio and Pr Marina Cavazzana's teams from Carnot Imagine. This study unveils a non-viral gene therapy approach for sickle cell disease using TALEN® technology, achieving over 50% normal hemoglobin expression in patient-derived cells. The edited hematopoietic stem and progenitor cells show promising long-term engraftment in preclinical models, paving the way for future clinical applications. 📰 https://lnkd.in/e4AZC9zc #GeneTherapy #Biotech #SickleCellDisease #TranslationalResearch #CarnotImagine #Cellectis
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications Thanks to a greatest team of authors! Arianna Moiani, Gil LETORT, Sabrina Lizot, Chloé FORAY, Diane Le Clerre, Sonal Temburni-Blake, Patrick Hong, Sophie Leduc, Noémie PINARD, Alan Maréchal, Eduardo Seclen, PhD, Alex Boyne, Louisa Mayer, Anne Chalumeau, Tristan FELIX, Robert Hong, Sylvain PULICANI, Roman Galetto, PhD, Agnès Gouble, Marina Cavazzana, Alexandre Juillerat, Annarita Miccio, Aymeric Duclert, philippe duchateau & Julien Valton Ph. D To read the press release: https://lnkd.in/euX9G4sm #genetherapy #celltherapy Nature Portfolio
-
Hear what Dr. Marvin, Transplant Surgeon at Geisinger Medical Center, had to say about how he uses TruGraf to help titrate immunosuppression management in this clip from the webinar: Using Gene Expression Profile Biomarkers as an Immunosuppression Guide in Post-Transplant Care. #Eurofins #KidneyTransplantation
-
Let's connect at #ISCT2024! Join our panel discussion on current state and future directions of process analytical technologies. We're elevating your process with cell collections, cell expansion, and fill-finish. Looking forward to seeing you there. #CellandGeneTherapy #CGT ISCT, International Society for Cell & Gene Therapy
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more: https://bit.ly/cellngene #CellandGeneTherapy #CellTherapy #GeneTherapy
-
-
Join us October 3 to explore common challenges and considerations for seamless viral vector tech transfer: https://okt.to/GDyBow Freda Cuneo and Kevin Taylor, MSAT experts in upstream and downstream production with more than three decades of combined experience, join Dr. James Cody to share valuable insights and lessons learned: - Approaches to bolster your program - MSAT best practices to avoid roadblocks - Real-world case study examples Cell & Gene Therapy Insights BioInsights #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat
Safeguard your viral vector tech transfer: considerations and case studies
Research and Development of Advanced Therapies
3moA shared view from ISCT, International Society for Cell & Gene Therapy Europe and The EBMT. It’s great to read it now in its final format in Cytotherapy.